Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Elixirgen Scientific Inc. has 1 pending office action in Biotechnology & Pharmaceuticals. The matter is concentrated with 1 distinct examiner and 1 distinct art unit, indicating a focused prosecution path rather than distribution across multiple examination assignments.
NOBLE, MARCIA STEPHENS is the busiest examiner, with 1 pending matter. Counsel can therefore direct immediate review toward the issues in that assigned application and align the response strategy with the applicable biotechnology examination context.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NOBLE, MARCIA STEPHENS | 1 | 67.2% | +39.5% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18786913 | Compositions And Methods For Differentiation Of Human Pluripotent Stem Cells Into Desired Cell Types | NOBLE, MARCIA STEPHENS | — |
| Art Unit | Apps |
|---|---|
| 1632 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18786913 | Compositions And Methods For Differentiation Of Human Pluripotent Stem Cells Into Desired Cell Types | NOBLE, MARCIA STEPHENS | 1632 | §103 | Non-Final OA | — | Pending | Jul 29, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialElixirgen Scientific Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Marcia Stephens Noble has the most, with 1 of Elixirgen Scientific Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
